SenesTech (NASDAQ:SNES – Get Free Report) is scheduled to release its earnings data after the market closes on Tuesday, November 12th. Analysts expect SenesTech to post earnings of ($3.20) per share for the quarter.
SenesTech (NASDAQ:SNES – Get Free Report) last announced its quarterly earnings results on Thursday, August 8th. The company reported ($3.08) earnings per share for the quarter, beating analysts’ consensus estimates of ($3.20) by $0.12. SenesTech had a negative net margin of 464.09% and a negative return on equity of 168.64%. The business had revenue of $0.46 million during the quarter, compared to analysts’ expectations of $0.49 million. During the same period last year, the business earned ($84.03) earnings per share. On average, analysts expect SenesTech to post $-11 EPS for the current fiscal year and $-5 EPS for the next fiscal year.
SenesTech Price Performance
Shares of SNES opened at $2.63 on Wednesday. SenesTech has a 1-year low of $1.90 and a 1-year high of $45.60. The firm has a 50-day simple moving average of $2.73 and a two-hundred day simple moving average of $4.84. The company has a current ratio of 4.68, a quick ratio of 3.49 and a debt-to-equity ratio of 0.05.
Wall Street Analyst Weigh In
View Our Latest Stock Report on SNES
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Recommended Stories
- Five stocks we like better than SenesTech
- Are Penny Stocks a Good Fit for Your Portfolio?
- 2 Alternative Internet Stocks Staging a Breakout in 2024
- What Are Trending Stocks? Trending Stocks Explained
- Discover the 3 Best-Performing Biotech IPO Stocks of 2024
- Profitably Trade Stocks at 52-Week Highs
- Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.